Skip to main content

Correction to: Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial

The Original Article was published on 01 November 2018

Correction

Following publication of the original article [1], the authors notified us that the citation within the Table 1 legend was not presented as initially requested. Also, the word “efficacy” was missed from the background section.

The original publication has been corrected. The incorrect and correct table citations as well as background information are presented below.

  • Originally published citation:

© 2018 Tassorelli C, Grazzi L, de Tommaso M, Pierangeli G, Martelletti P, Rainero I, Dorlas S, Geppetti P, Ambrosini A, Sarchielli P, Liebler E, Barbanti P, PRESTO Study Group (2018) Non-invasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study [published online June 15, 2018]. Neurology: https://doi.org/10.1212/WNL.0000000000005857. www.neurology.org. Adapted with permission

Abbreviations: DB Double-blind, NA Not applicable, nVNS Non-invasive vagus nerve stimulation, SD Standard deviation

aNo. of days the patient typically takes acute migraine medication per month. bPatients with no reported baseline severity were excluded from this analysis

  • Corrected citation:

© 2018 Tassorelli C, Grazzi L, de Tommaso M, et al. Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study. Neurology. 2018;91(4):e364-e373. Adapted with permission

  • Original Background paragraph:

Opioids should be discouraged for the acute treatment of migraine due to significant safety concerns and lack of documented but remain frequently used in the emergency department setting, which significantly increases healthcare costs

  • Corrected Background paragraph:

Opioids should be discouraged for the acute treatment of migraine due to significant safety concerns and lack of documented efficacy but remain frequently used in the emergency department setting, which significantly increases healthcare costs

Reference

  1. 1.

    Martelletti P et al (2018) Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial. J Headache Pain 19:101. https://doi.org/10.1186/s10194-018-0929-0

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Consortia

Corresponding author

Correspondence to Eric Liebler.

Additional information

The original article can be found online at https://doi.org/10.1186/s10194-018-0929-0

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Martelletti, P., Barbanti, P., Grazzi, L. et al. Correction to: Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial. J Headache Pain 19, 120 (2018). https://doi.org/10.1186/s10194-018-0949-9

Download citation

\